Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Chestnuts on Postprandial Glycaemic Response
Sponsor: Monash University
Summary
Nut consumption is known to improve health outcomes, such as reducing the risk of chronic diseases like diabetes, cognitive impairment, and cardiovascular diseases. While most research has focused on walnuts and almonds, there is limited information on the health benefits of chestnuts. Chestnuts are unique among tree nuts due to their high starch and fibre content, along with vitamins E and C, minerals (potassium, phosphorus, magnesium), and polyphenols. Evidence from in vitro and animal studies suggests that chestnuts may positively affect health by regulating the gut microbiome, lowering the glycaemic index, and providing antioxidant benefits. The food industry is also exploring new uses for chestnuts, particularly in gluten-free products, due to their nutritional benefits and good taste. Nonetheless, no research has investigated the health effects of chestnuts in humans. By addressing this gap in the literature, the study may lead to the development of new dietary strategies for improved health outcomes.
Official title: Postprandial Effects of Chestnuts on Glycaemic Response: a Cross-over Trial in Healthy Adults
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2025-06-06
Completion Date
2026-04-30
Last Updated
2026-03-10
Healthy Volunteers
Yes
Conditions
Interventions
Chestnut meal
Participants will receive an isocaloric baked meal with chestnut flour.
Control meal
Participants will receive an isocaloric baked meal without chestnut flour.
Locations (1)
Monash University
Melbourne, Victoria, Australia